Corbus Pharmaceuticals Holding Stock Analysis

Corbus Stock Analysis Notes

About 93.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.82. Some equities with similar Price to Book (P/B) outperform the market in the long run. Corbus Pharmaceuticals recorded a loss per share of 4.24. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 14th of February 2023. Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. The company was incorporated in 2009 and is based in Norwood, Massachusetts. Corbus Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people. For more info on Corbus Pharmaceuticals Holding please contact Yuval Cohen at 617 963 0100 or go to https://www.corbuspharma.com.

Corbus Pharmaceuticals Investment Alerts

Corbus Pharmaceuticals Upcoming and Recent Events

Corbus Largest EPS Surprises

View All Earnings Estimates

Corbus Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Corbus Pharmaceuticals Thematic Classifications

Corbus Stock Institutional Investors

Note, although Corbus Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Corbus Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 104.01 M.

Corbus Profitablity

Management Efficiency

Corbus Pharmaceuticals has return on total asset (ROA) of (0.2718) % which means that it has lost $0.2718 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4489) %, meaning that it created substantial loss on money invested by shareholders. Corbus Pharmaceuticals' management efficiency ratios could be used to measure how well Corbus Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 07/19/2025, Return On Tangible Assets is likely to drop to -0.27. In addition to that, Return On Capital Employed is likely to drop to -0.36. At this time, Corbus Pharmaceuticals' Total Current Liabilities is relatively stable compared to the past year. As of 07/19/2025, Liabilities And Stockholders Equity is likely to grow to about 163.7 M, while Non Current Liabilities Total is likely to drop slightly above 1.6 M.

Technical Drivers

As of the 19th of July, Corbus Pharmaceuticals shows the Downside Deviation of 4.66, mean deviation of 4.02, and Risk Adjusted Performance of 0.1346. Corbus Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Corbus Pharmaceuticals Price Movement Analysis

Corbus Pharmaceuticals Insider Trading Activities

Corbus Pharmaceuticals Outstanding Bonds

Corbus Pharmaceuticals Predictive Daily Indicators

Corbus Pharmaceuticals Corporate Filings

Corbus Pharmaceuticals Forecast Models

Corbus Pharmaceuticals' time-series forecasting models are one of many Corbus Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Corbus Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Corbus Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Corbus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Corbus Pharmaceuticals. By using and applying Corbus Stock analysis, traders can create a robust methodology for identifying Corbus entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Corbus analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Corbus analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Corbus Pharmaceuticals Holding stock analysis indicators help investors evaluate how Corbus Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Corbus Pharmaceuticals shares will generate the highest return on investment. By understating and applying Corbus Pharmaceuticals stock analysis, traders can identify Corbus Pharmaceuticals position entry and exit signals to maximize returns.

When running Corbus Pharmaceuticals' price analysis, check to measure Corbus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corbus Pharmaceuticals is operating at the current time. Most of Corbus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Corbus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corbus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Corbus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.